288 filings
Page 9 of 15
4
Brenner Louis MD
4 Dec 19
Allena Pharmaceuticals / LOUIS MD BRENNER ownership change
9:27pm
8-K
ALNAQ
Allena Pharmaceuticals, Inc.
4 Dec 19
Allena Pharmaceuticals Provides Updates on Reloxaliase Development Program and Corporate Activities
5:13pm
10-Q
2019 Q3
ALNAQ
Allena Pharmaceuticals, Inc.
Quarterly report
13 Nov 19
8:11am
8-K
ALNAQ
Allena Pharmaceuticals, Inc.
13 Nov 19
Allena Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Business Update
8:00am
8-K
ALNAQ
Allena Pharmaceuticals, Inc.
7 Nov 19
Allena Pharmaceuticals Reports Positive Reloxaliase Topline Results fromURIROX-1 Trial and from Study 206
8:19am
10-Q
2019 Q2
ALNAQ
Allena Pharmaceuticals, Inc.
Quarterly report
7 Aug 19
8:04am
8-K
ALNAQ
Allena Pharmaceuticals, Inc.
7 Aug 19
Allena Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Business Update
8:00am
SC 13G
Altium Capital Management LP
2 Jul 19
Allena Pharmaceuticals, Inc.
12:00am
424B5
ALNAQ
Allena Pharmaceuticals, Inc.
28 Jun 19
Prospectus supplement for primary offering
6:25am
8-K
ALNAQ
Allena Pharmaceuticals, Inc.
28 Jun 19
Allena Pharmaceuticals Announces $10.0 Million Registered Direct Offering of Common Stock
6:06am
8-K
ALNAQ
Allena Pharmaceuticals, Inc.
21 Jun 19
Other Events
8:06am
4
ALNAQ
Allena Pharmaceuticals, Inc.
7 Jun 19
Allena Pharmaceuticals / James N Topper ownership change
9:22am
4
ALNAQ
Allena Pharmaceuticals, Inc.
7 Jun 19
Allena Pharmaceuticals / ROBERT I TEPPER ownership change
9:20am
4
Santini Gino
7 Jun 19
Allena Pharmaceuticals / GINO SANTINI ownership change
9:18am
4
ALNAQ
Allena Pharmaceuticals, Inc.
7 Jun 19
Allena Pharmaceuticals / Alexey L Margolin ownership change
9:16am
4
Hack Andrew A. F.
7 Jun 19
Allena Pharmaceuticals / Andrew A. F. Hack ownership change
9:14am
4
ALNAQ
Allena Pharmaceuticals, Inc.
7 Jun 19
Allena Pharmaceuticals / Robert Alexander ownership change
9:11am
8-K
ALNAQ
Allena Pharmaceuticals, Inc.
7 Jun 19
Submission of Matters to a Vote of Security Holders
8:59am
8-K
ALNAQ
Allena Pharmaceuticals, Inc.
4 Jun 19
Allena Pharmaceuticals Announces Interim Results from Study 206 of Reloxaliase in High Risk Patients with Advanced Oxalate Disorders
8:01am
10-Q
2019 Q1
ALNAQ
Allena Pharmaceuticals, Inc.
Quarterly report
8 May 19
8:03am